Biofavi
Original price was: 400৳ .360৳ Current price is: 360৳ .
Description
Medicine Overview of Biofavi 200mg Tablet
- Diarrhea
- Reduced number of white blood cells (neutrophils)
- Triglyceride levels in blood have increased.Increased uric acid level in blood
- Higher levels of liver enzymes
Total treatment course: 3600 mg/day for 5 days (1800 mg on day one and 1800 mg/day thereafter).
Favipiravir is an antiviral medication that inhibits the influenza virus’s RNA polymerase. RNA polymerase is an enzyme that allows the virus to replicate and spread. Favipiravir inhibits RNA polymerase, which prevents the virus from replicating and spreading.
Favipiravir is a prodrug, which means it is converted to its active form, favipiravir-ribofuranosyl-5′-triphosphate (favipiravir-RTP), in the body. Favipiravir-RTP then inhibits RNA polymerase by competing with its natural substrate, adenosine triphosphate (ATP). This competition keeps the virus from incorporating new nucleotides into its RNA, preventing it from replicating.
Favipiravir works against both influenza A and B viruses. It is also effective against some other RNA viruses, such as yellow fever virus and West Nile virus.
Increased uric acid level in blood
Decreased white blood cell count (neutrophils),Increased liver enzymes
Increased triglyceride level in blood
Pregnant women should avoid using Favipiravir.
Favipiravir can cause birth abnormalities and harms unborn children.Women who are pregnant or want to become pregnant should avoid using favipiravir.
Lactation:
Breastfeeding women should avoid favipiravir.
Favipiravir is detrimental to nursing newborns.
Women who are breastfeeding should avoid taking favipiravir.
Store below 30°C temperature, protected from light & moisture. Keep out of the reach of children.
